Quality is the top priority at Novartis and the shared responsibility of all associates. Our facilities operate in full compliance with cGMP regulations, which are an integral part of the Novartis comprehensive quality assurance system for biopharmaceutical products.
In addition, Novartis fully complies with the rigorous internal quality standards applied by the worldwide Novartis Group across all its facilities. The Novartis manufacturing facilities are inspected and approved by local and international health authorities like FDA, EMEA and PMDA.
The regulatory department of Novartis is highly experienced with a proven track record of approved products. Quality at every stage of the process ensures that the product fully meets all your requirements.
We believe partnership is for the long term. And for your sustainable success.